US Patent 9404926 Immune gene signatures in cancer
All edits
Edits on 29 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 5 Dec, 2023
Golden AI
Edits made to:
Article (+260 characters)
Article
Patent abstract
This invention relates to methods for selecting a treatment, treating, and predicting survival time in subjects with cancer, such as colorectal cancer, based on tumor expression levels of chemokines, cytotoxic genes, and/or dendritic cell genes.
Edits on 29 Sep, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Andrey Loboda0
Domenico Coppola0
James J. Mulé0
Michael V. Nebozhyn0
Timothy J. Yeatman0
Edits on 14 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09404926 Immune gene signatures in cancer US Patent 9404926 Immune gene signatures in cancer
Infobox
Patent Number
094049260
Patent Number
94049260
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
094049260
Date of Patent
August 2, 2016
0Patent Application Number
135753540
Date Filed
January 28, 2011
0Official Website
Patent Primary Examiner
Edits on 5 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 7 Jan, 2022
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 09404926 Immune gene signatures in cancer
Infobox
Is a
Patent jurisdiction
Patent number
09404926
Date of patent
August 2, 2016
Patent application number
13575354
Date Filed
January 28, 2011
Patent primary examiner
Find more entities like US Patent 9404926 Immune gene signatures in cancer
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
